Wed, 11 March 2015
MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks. |
Wed, 11 March 2015
Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out. |